According to a study, people infected with COVID-19 during the omicron era have an increased risk of diabetes and related diseases, demonstrating that the virus’s long-term dangers have persisted since the strain began spreading.
According to a study of nearly 24,000 patients conducted by researchers at Cedars-Sinai Medical Center in Los Angeles during omicron’s dominance, they predicted, “In the first 90 days, the rate of newly diagnosed diabetes, high blood pressure, and high levels of cholesterol. Vaccination appeared to help reduce these risks more after COVID infection than before.”
Omicron was considered a milder strain of COVID than previous strains, resulting in Delta. The strain emerged from China in early 2020 and had lower hospitalization and death rates. Since late 2021, omicron has been sweeping the world. Most US infections have been traced back to the variant and its descendants, emphasizing the importance of controlling diabetes in COVID patients.
“Most people should be screened for diabetes at the age of 35,” said Alan Kwan, a Cedars-Sinai cardiologist who contributed to the report published Tuesday in JAMA Network Open. “They should also be screened every three years.”
COVID was initially thought to be primarily a respiratory illness. Still, it has since been shown to harm some patients in various ways that can last for years after infection. Diabetes, which occurs when the body loses its ability to regulate blood sugar levels closely, can harm the heart, kidney, and eye tissues.
During the omicron era, new diabetes diagnoses were nearly three times more common among unvaccinated people after infection than before. High blood pressure, cholesterol, and other blood fat levels were nearly twice as high in the unvaccinated after the illness.
Diabetes risk remained roughly the same before and after the infection in vaccinated people who got COVID, while the risk for other diseases decreased.
Read More News: Click Here